← Browse by Condition
Medical Condition
metastatic urothelial carcinoma
Total Trials
3
Recruiting Now
3
Trial Phases
Phase 1, Phase 1, Phase 2, Phase 4
NCT06439836 Phase 1
Recruiting
Pembrolizumab Plus CA-4948 for the Treatment of Patients With Progressive Metastatic Urothelial Cancer Despite Prior Immunotherapy
Enrollment
27 pts
Location
United States
Sponsor
National Cancer Institute (NCI...
NCT04724018 Phase 1, Phase 2
Recruiting
Sacituzumab Govitecan Plus EV in Metastatic UC
Enrollment
106 pts
Location
United States
Sponsor
Dana-Farber Cancer Institute
NCT06862219 Phase 4
Recruiting
A Safety Study of Enfortumab Vedotin in Indian Adults With Urothelial Cancer
Enrollment
100 pts
Location
India
Sponsor
Astellas Pharma Global Develop...